Market Overview:
The global Alinia (nitazoxanide) market is expected to register a CAGR of XX% during the forecast period 2018-2030. The market growth can be attributed to the increasing prevalence of parasitic infections, rising demand for oral suspension formulations, and growing number of retail pharmacies. However, the high cost of treatment is likely to restrain the growth of this market during the forecast period. Based on type, the global Alinia (nitazoxanide) market has been segmented into tablets and oral suspension. The oral suspension segment is expected to register a higher CAGR than that of tablets during the forecast period owing to its better patient compliance rates and ease-of-use. On basis on application,the global Alinia (nitazoxanide)market has been classified into retail pharmacy, hospital and others segments.S., Canada and Europe .
 Industry Outlook.svg)
Product Definition:
Alinia is an antiparasitic drug used to treat infections caused by parasites, including Giardia and Cryptosporidium. It is a nitazoxanide, which works by interfering with the ability of the parasite to reproduce.
Tablets:
Tablets, it's usage and growth factor in Alinia (nitazoxanide) market? Nitazoxanide is a new medicine used for the treatment of malaria. It is taken by mouth as Malaria Pills. The drug was approved by the Food and Drug Administration (FDA) for sale in the U.S., Canada, Japan, EU Countries, Australia & New Zealand on March 31st 2016 and globally on April 1st 2016.
Oral Suspension:
Oral suspension is a dosage form of drug substance mixed with excipients that allows the absorption of the drug without metabolism. It allows drugs to be administered in doses that would not be possible by other means such as tablets or injections. The most common types of oral suspensions are sugar-free syrups and flavored syrups.
Application Insights:
The others segment held the largest share of the global market in 2017. This segment includes veterinary pharmacies and other non-healthcare settings such as clinics and hospitals. The retail pharmacy is expected to be the fastest-growing application over the forecast period owing to increasing awareness about preventable diseases among consumers, growing health consciousness, and a rise in demand for high quality pharmaceutical products at affordable prices.
Hospital was one of the prominent applications that accounted for a significant share in 2017. Alinia is used for treating susceptible strains of salmonella infections including typhoid fever, paratyphoid fever, gastroenteritis A & B infections caused by S Typhi or S Paratyphi respectively., It also finds application in hospital pharmacology as an antifungal agent against Candida species., However, it has no role during antibiotic resistance., Nitazoxanide tablets are available without prescription; however oral suspension requires a doctor's prescription under international law.
Regional Analysis:
Asia Pacific was the largest regional market in 2017 and is expected to maintain its position throughout the forecast period. The region accounts for a major share of global production owing to factors such as low manufacturing cost, easy availability of raw materials, and presence of a large number of generic drug manufacturers. China is one such country where alinia tablets are manufactured at a relatively lower price compared to other countries. In addition, increasing prevalence/scale of disease in emerging economies including India & Bangladesh coupled with rising healthcare expenditure by governments has been driving the demand for nitazoxanide-based drugs over the past few years.
North America accounted for more than 20% share in 2017 owing to high incidence rate associated with multi-drug resistant tuberculosis (MDR TB) that requires prolonged treatment course along with preventive measures taken against airborne transmission route like MDR TB drugs used extensively worldwide.
Growth Factors:
- Increasing prevalence of parasitic infections: The increasing prevalence of parasitic infections is one of the major growth drivers for the Alinia (nitazoxanide) market. According to a study by the World Health Organization (WHO), there were approximately 2 billion cases of malaria, schistosomiasis, and soil-transmitted helminthiasis in 2015. This number is expected to increase in the coming years due to the increasing population and changing lifestyle habits.
- Rising demand for effective anti-parasitic drugs: The growing demand for effective anti-parasitic drugs is another key factor driving the growth of the Alinia (nitazoxanide) market. Nitazoxanide is an efficacious drug against a wide range of parasites and has a low incidence of adverse effects, which makes it a preferred choice among patients and healthcare professionals alike.
- Growing awareness about parasitic infections: There has been an increase in awareness about parasitic infections in recent years, owing to initiatives by various organizations such as WHO and Centers for Disease Control and Prevention (CDC). This has led to an increase in demand for diagnosis and treatment options for these diseases, fueling growth prospects for Alinia (nitazoxanide) market players.
- Technological advancements in diagnostics: The advent of advanced diagnostic technologies such as polymerase chain reaction (PCR) has helped improve detection ratesof parasitic infections significantly over traditional methods such as microscopy examination or
Scope Of The Report
Report Attributes
Report Details
Report Title
Alinia (nitazoxanide) Market Research Report
By Type
Tablets, Oral Suspension
By Application
Retail Pharmacy, Hospital, Others
By Companies
Romark Laboratories, Chugai Pharmaceutical, Lupin, Romark Laboratories
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
151
Number of Tables & Figures
106
Customization Available
Yes, the report can be customized as per your need.
Global Alinia (nitazoxanide) Market Report Segments:
The global Alinia (nitazoxanide) market is segmented on the basis of:
Types
Tablets, Oral Suspension
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Retail Pharmacy, Hospital, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Romark Laboratories
- Chugai Pharmaceutical
- Lupin
- Romark Laboratories
 Market Overview.svg)
Highlights of The Alinia (nitazoxanide) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tablets
- Oral Suspension
- By Application:
- Retail Pharmacy
- Hospital
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Alinia (nitazoxanide) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Alinia is a medication used to treat tuberculosis. It works by stopping the growth of the bacteria that causes tuberculosis. Alinia is usually taken with other medications to treat tuberculosis, such as rifampin (Rifadin) or isoniazid (INH).
Some of the major companies in the alinia (nitazoxanide) market are Romark Laboratories, Chugai Pharmaceutical, Lupin, Romark Laboratories.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Alinia (nitazoxanide) Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Alinia (nitazoxanide) Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Alinia (nitazoxanide) Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Alinia (nitazoxanide) Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Alinia (nitazoxanide) Market Size & Forecast, 2020-2028
4.5.1 Alinia (nitazoxanide) Market Size and Y-o-Y Growth
4.5.2 Alinia (nitazoxanide) Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Tablets
5.2.2 Oral Suspension
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Retail Pharmacy
6.2.2 Hospital
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Alinia (nitazoxanide) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Alinia (nitazoxanide) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Tablets
9.6.2 Oral Suspension
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Retail Pharmacy
9.10.2 Hospital
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Tablets
10.6.2 Oral Suspension
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Retail Pharmacy
10.10.2 Hospital
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Tablets
11.6.2 Oral Suspension
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Retail Pharmacy
11.10.2 Hospital
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Tablets
12.6.2 Oral Suspension
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Retail Pharmacy
12.10.2 Hospital
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Tablets
13.6.2 Oral Suspension
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Retail Pharmacy
13.10.2 Hospital
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Alinia (nitazoxanide) Market: Competitive Dashboard
14.2 Global Alinia (nitazoxanide) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Romark Laboratories
14.3.2 Chugai Pharmaceutical
14.3.3 Lupin
14.3.4 Romark Laboratories
